Research and Markets has announced the addition of the "Pharmaceutical Excipients Market (2016-2022)" report to their offering.

Pharmaceutical excipients can be defined as components of a finished drug product other than the active pharmaceutical ingredient (API) which are added during formulation for a specific purpose such as to aid in the handling of the active substance concerned such as by facilitating powder flowability or non-stick properties etc apart from these other major functions of excipients are sweetners, binders, coatings, colorants and many more. Global growth of the pharmaceutical industry is expected to remain the key growth driver for pharmaceutical excipients during the period of study.

Geographically, Europe dominated the pharmaceutical excipients market driven by presence of a large number of pharmaceutical drug manufacturers in Europe has led to their large market share in the market. Europe was followed by North America and Asia-Pacific as second and third largest market for the pharmaceutical excipients market.

Asia Pacific is projected to have the fastest growth, owing to rapidly expanding pharmaceutical industry in the region and growing number of pharmaceutical players in developing nations such as China and India in this region.

Companies Mentioned:

  • Ashland Inc.
  • BASF SE
  • The DOW Chemical Company
  • FMC Corporation
  • Roquette Group
  • Evonik Industries AG
  • Associated British Foods PLC
  • The Lubrizol Corporation
  • Archer Daniels Midland Company
  • Croda International PLC

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Pharmaceutical excipients Market, By Product

7. Pharmaceutical excipients Market, By Functionality

8. Pharmaceutical excipients Market, By Geography

9. Market Entropy

10. Company Profiles

11. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/bnktv3/pharmaceutical